These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
133 related articles for article (PubMed ID: 38057118)
61. Findings from a multicentre, observational study on reproductive outcomes in women with unexplained recurrent pregnancy loss: the OTTILIA registry. Grandone E; Tiscia GL; Mastroianno M; Larciprete G; Kovac M; Tamborini Permunian E; Lojacono A; Barcellona D; Bitsadze V; Khizroeva J; Makatsarya A; Cacciola R; Martinelli I; Bucherini E; De Stefano V; Lodigiani C; Colaizzo D; De Laurenzo A; Piazza G; Margaglione M Hum Reprod; 2021 Jul; 36(8):2083-2090. PubMed ID: 34195794 [TBL] [Abstract][Full Text] [Related]
62. Successful pregnancy with low molecular weight heparin in two women with recurrent miscarriage of unknown etiology. Miyashita Y; Waguri M; Nakanishi I; Suehara N; Fujita T Am J Reprod Immunol; 2003 Feb; 49(2):90-2. PubMed ID: 12765347 [TBL] [Abstract][Full Text] [Related]
63. Progestogens for preventing miscarriage: a network meta-analysis. Devall AJ; Papadopoulou A; Podesek M; Haas DM; Price MJ; Coomarasamy A; Gallos ID Cochrane Database Syst Rev; 2021 Apr; 4(4):CD013792. PubMed ID: 33872382 [TBL] [Abstract][Full Text] [Related]
64. Low-Molecular-Weight Heparin and Fondaparinux Use in Pediatric Patients With Obesity. Garner MP; Onuoha CP; Fenn NE Ann Pharmacother; 2021 May; 55(5):666-676. PubMed ID: 32864984 [TBL] [Abstract][Full Text] [Related]
65. Low dose aspirin and low-molecular-weight heparin in the treatment of pregnant Libyan women with recurrent miscarriage. Elmahashi MO; Elbareg AM; Essadi FM; Ashur BM; Adam I BMC Res Notes; 2014 Jan; 7():23. PubMed ID: 24405979 [TBL] [Abstract][Full Text] [Related]
66. Comparison of 2 approaches in management of pregnant women with inherited trombophilias: Prospective analytical cohort study. Dugalic S; Petronijevic M; Stefanovic A; Stefanovic K; Petronijevic SV; Stanisavljevic D; Kepeci SP; Milincic N; Pantic I; Perovic M Medicine (Baltimore); 2019 Aug; 98(34):e16883. PubMed ID: 31441864 [TBL] [Abstract][Full Text] [Related]
67. An examination of care received by women with recurrent miscarriage and infertility against guideline-based key performance indicators. Linehan L; Hennessy M; O'Donoghue K Eur J Obstet Gynecol Reprod Biol; 2023 Mar; 282():17-23. PubMed ID: 36621261 [TBL] [Abstract][Full Text] [Related]
68. Comparison of Fondaparinux and Low-Molecular-Weight Heparin in the Treatment of Portal Vein Thrombosis in Cirrhosis. Senzolo M; Piano S; Shalaby S; Tonon M; Tonello S; Zanetto A; Sacerdoti D; Simioni P; Bombonato G; Burra P; Angeli P Am J Med; 2021 Oct; 134(10):1278-1285.e2. PubMed ID: 34197784 [TBL] [Abstract][Full Text] [Related]
69. A feasibility trial of screening women with idiopathic recurrent miscarriage for high uterine natural killer cell density and randomizing to prednisolone or placebo when pregnant. Tang AW; Alfirevic Z; Turner MA; Drury JA; Small R; Quenby S Hum Reprod; 2013 Jul; 28(7):1743-52. PubMed ID: 23585559 [TBL] [Abstract][Full Text] [Related]
70. Comparison of the efficacy of low-molecular-weight heparin and fondaparinux sodium after total knee arthroplasty: a retrospective cohort study. Yang T; Liu Z; Zhang B; Zhang J; Ma A; Cao D; Chen D BMC Musculoskelet Disord; 2023 Jul; 24(1):552. PubMed ID: 37403062 [TBL] [Abstract][Full Text] [Related]
71. Testing for inherited thrombophilia in recurrent miscarriage. de Jong PG; Goddijn M; Middeldorp S Semin Reprod Med; 2011 Nov; 29(6):540-7. PubMed ID: 22161466 [TBL] [Abstract][Full Text] [Related]
72. First Trimester Anticoagulant Exposure and Adverse Pregnancy Outcomes in Women with Preconception Venous Thromboembolism: A Nationwide Cohort Study. Søgaard M; Skjøth F; Nielsen PB; Beyer-Westendorf J; Larsen TB Am J Med; 2022 Apr; 135(4):493-502.e5. PubMed ID: 34798098 [TBL] [Abstract][Full Text] [Related]
73. The safety and efficacy of tumor necrosis factor-alpha inhibitor on pregnancy outcomes in patients with unexplained recurrent miscarriage. Mu F; Wang C; Liu L; Zeng X; Wang F Immunobiology; 2024 May; 229(3):152808. PubMed ID: 38735178 [TBL] [Abstract][Full Text] [Related]
74. Perinatal outcomes of women with a prior history of unexplained recurrent miscarriage. Dempsey MA; Flood K; Burke N; Fletcher P; Kirkham C; Geary MP; Malone FD J Matern Fetal Neonatal Med; 2015 Mar; 28(5):522-5. PubMed ID: 24824106 [TBL] [Abstract][Full Text] [Related]
75. Aspirin plus heparin or aspirin alone in women with recurrent miscarriage. Kaandorp SP; Goddijn M; van der Post JA; Hutten BA; Verhoeve HR; Hamulyák K; Mol BW; Folkeringa N; Nahuis M; Papatsonis DN; Büller HR; van der Veen F; Middeldorp S N Engl J Med; 2010 Apr; 362(17):1586-96. PubMed ID: 20335572 [TBL] [Abstract][Full Text] [Related]
76. THE ROLE OF LOW MOLECULAR WEIGHT HEPARIN IN WOMEN WITH HEREDITARY THROMBOPHILIA FOR GOOD PERINATAL OUTCOME. Sokol V; Ivanišević M; Herman M; Đelmiš J Acta Clin Croat; 2016 Jun; 55(2):309-15. PubMed ID: 28394549 [TBL] [Abstract][Full Text] [Related]
77. Pentasaccharides for the treatment of deep vein thrombosis. Brandao GM; Junqueira DR; Rollo HA; Sobreira ML Cochrane Database Syst Rev; 2017 Dec; 12(12):CD011782. PubMed ID: 29199766 [TBL] [Abstract][Full Text] [Related]
78. Administration of prednisolone and low molecular weight heparin in patients with repeated implantation failures: a cohort study. Siristatidis C; Dafopoulos K; El-Khayat W; Salamalekis G; Anifandis G; Vrantza T; Elsadek M; Papantoniou N Gynecol Endocrinol; 2018 Feb; 34(2):136-139. PubMed ID: 28949261 [TBL] [Abstract][Full Text] [Related]
79. Benefits and risks of low molecular weight heparin use on reproductive outcomes: A retrospective cohort study. Chen M; Chen YT; Chen CM; Wu WJ; Lin WH; Ma GC Taiwan J Obstet Gynecol; 2022 Sep; 61(5):812-817. PubMed ID: 36088049 [TBL] [Abstract][Full Text] [Related]
80. Low-molecular-weight heparin in the prevention of unexplained recurrent miscarriage: a systematic review and meta-analysis. Scarrone M; Salmeri N; Buzzaccarini G; Canti V; Pasi F; Papaleo E; Rovere-Querini P; Candiani M; Alteri A; Busnelli A; Vanni VS Sci Rep; 2024 Jun; 14(1):14168. PubMed ID: 38898143 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]